Heart Test Laboratories, Inc. Stock
Equities
HSCS
US42254E3027
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.69 USD | +3.45% | -8.23% | -66.73% |
Financials (USD)
Sales 2024 * | 59.3K | Sales 2025 * | 1.9M | Capitalization | 3.61M |
---|---|---|---|---|---|
Net income 2024 * | -6M | Net income 2025 * | -9M | EV / Sales 2024 * | 60.8 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.9 x |
P/E ratio 2024 * |
-0.28
x | P/E ratio 2025 * |
-0.54
x | Employees | 12 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.99% |
1 day | +3.45% | ||
1 week | -8.23% | ||
Current month | +3.45% | ||
1 month | -39.79% | ||
3 months | -53.13% | ||
6 months | -74.61% | ||
Current year | -66.73% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Simpson
CEO | Chief Executive Officer | 55 | 13-07-24 |
Danielle Watson
DFI | Director of Finance/CFO | 42 | 21-10-31 |
Aaron Peterson
CTO | Chief Tech/Sci/R&D Officer | - | 14-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Hilz
COO | Chief Operating Officer | 66 | 13-07-24 |
David R. Wells
BRD | Director/Board Member | 61 | 22-12-27 |
Andrew Simpson
CEO | Chief Executive Officer | 55 | 13-07-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-03 | 5.69 | +3.45% | 61,342 |
24-05-31 | 5.5 | -19.24% | 105,869 |
24-05-30 | 6.81 | +0.27% | 97,415 |
24-05-29 | 6.792 | +5.96% | 45,494 |
Delayed Quote Nasdaq, June 03, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-66.73% | 3.61M | |
-21.46% | 2.74B | |
-12.64% | 80.66M |
- Stock Market
- Equities
- HSCS Stock